Brokers can’t agree on GSK shares but I’m watching its cancer pipeline
Mark Hartley weighs up the case for GSK shares after noticing a large discrepancy in broker targets. But are they focusing on the right thing? The post Brokers can’t agree on GSK shares but I’m watching its cancer pipeline appeared first on The Twelfth Magpie.
Mark Hartley weighs up the case for GSK shares after noticing a large discrepancy in broker targets. But are they focusing on the right thing? The post Brokers can’t agree on GSK shares but I’m watching its cancer pipeline appeared first on The Twelfth Magpie.
What's Your Reaction?
